CE Mark Approval for autologous blood filter
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter
HemoClear presents at NSA, 18-20 November 2020
As a proud sponsor, HemoClear is attending the 28th Nigerian Society of Anaesthetists Annual Scientific Conference. Dr Rosita Bihariesingh has been at the
HemoClear presents at BMSS Annual Conference, 4-6 November 2020
HemoClear attends the Bloodless Medicine & Surgery Society 2020 Annual Scientific Conference. Our Chief Medical Officer, Dr Arno Nierich, will present
Ziekenhuis COVID-19 plasma collectie met HemoClear
COVID-19 plasma donatie geeft vroeg in het genezingsproces een hogere opbrengst van antistoffen dan later in dat proces. https://www.rtvoost.nl/nieuws/1271
COVID-19 plasma behandeling met HemoClear
Zwolle, 14 september 2020. Het Academisch Medisch Centrum (AZP) in Paramaribo, Suriname, heeft met succes onderzoek gedaan naar een efficiënte methode om
HemoClear selected for EIT Health Bridgehead Europe programme
The renowned European Institute for Innovation and Technology (EIT) has selected HemoClear to participate in the Bridgehead Europe programme. Best-in-class
HemoClear Is Pleased To Partner With Oost NL
In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options t
Pregnancy Increases Risk Of Transfusion Reactions
An estimated 4 million women need a blood transfusion after giving birth annually. Now new research has found that their pregnancies put these women are at
Alternative Use HemoClear Offers COVID-19 Convalescent Plasma
8 April 2020, Zwolle – In the fight against COVID-19, HemoClear’s current top priority is to help save lives, with COVID-19 convalescent plasma the
Coronavirus Epidemic Exacerbates Global Blood Shortage
The persisting coronavirus epidemic is drying up Asian blood banks, further increasing the global blood shortage. Blood supplies fail the demand for emerge